a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders
Industry Biotechnology
A.I.dvisor tells us that ANVS and ADXN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANVS and ADXN's prices will move in lockstep.
Ticker / NAME | Correlation To ANVS | 1D Price Change % | ||
---|---|---|---|---|
ANVS | 100% | -5.94% | ||
ADXN - ANVS | 33% Poorly correlated | -4.98% | ||
EWTX - ANVS | 33% Poorly correlated | -1.17% | ||
TNYA - ANVS | 29% Poorly correlated | -3.35% | ||
ZVSA - ANVS | 26% Poorly correlated | -9.60% | ||
ATXI - ANVS | 26% Poorly correlated | -3.59% | ||
More |